Please provide your email address to receive an email when new articles are posted on . Overall, 47 donors in the study developed sustained low eGFR or moderate-severe albuminuria. Median time for the ...

Please provide your email address to receive an email when new articles are posted on . Researchers evaluated the risk of adverse outcomes in older patients across categories of eGFR. The database ...

A cross-sectional study found that severe anemia was common in patients with chronic kidney disease (CKD) and was associated with lower glomerular filtration rate (eGFR) and multiple adverse outcomes.

Black Diamond Therapeutics, Inc. is developing a next-generation EGFR inhibitor with promising early data in lung cancer. BDTX-1535 targets EGFR mutations, especially resistance drivers, with key data ...

SEATTLE—Living kidney donors should not be considered to have chronic kidney disease (CKD) if their renal function after nephrectomy falls to a level that usually would be considered CKD, researchers ...

Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib. In addition, they suggest a combined drug treatment ...

Investigators conducted a subgroup analysis of patients with eGFR values of 20 mL/min/1.73 m2 or less in the phase 3 ADVOCATE trial. Avacopan, an orally administered C5a receptor inhibitor approved ...

In patients with breast cancer, high expression of epidermal growth factor receptor (EGFR) should not always be considered a sign of a bad prognosis, according to a study that evaluated data on more ...

Blood pressure variability (BPV) in hypertensive patients is increasingly attracting the attention of clinicians and scientists as a way to identify patients at a higher risk of cardiovascular events ...

A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...